正邦科技(002157.SZ):10月生豬銷售收入11.71億元 環比下降9.03%
格隆匯11月6日丨正邦科技(002157.SZ)公佈,公司2019年10月銷售生豬31.41萬頭,環比下降39.83%,同比下降38.27%;銷售收入11.71億元,環比下降9.03%,同比增長42.18%。
商品豬銷售均價34.02元/公斤,較上月增幅26.19%。
2019年1-10月,公司累計銷售生豬481.05萬頭,同比增長8.72%;累計銷售收入84.84億元,同比增長44.83%。
2019年10月,公司生豬銷量環比及同比下降幅度較大的主要原因是公司根據市場情況,繼續落實養大豬策略,全年累計出欄量550-600萬頭的經營計劃保持不變。
2019年1-10月累計銷售收入同比增幅較大的主要原因是近期生豬價格上漲較快所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.